Pedmark

Fennec Pharmaceuticals Announces FDA Acceptance of New Drug Application Resubmission for Pedmark Research Triangle Park, NC, June 22, 2021 – Fennec Pharmaceuticals Inc. (NASDAQ: FENC; […]

Read more

tisotumab vedotin

tisotumab vedotin Genmab and Seagen Announce U.S. FDA Filing Acceptance for Priority Review of Tisotumab Vedotin Biologics License Application for Patients with Recurrent or Metastatic […]

Read more
1 2 3 61